Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.
Lakefront Biotherapeutics - Sponsored ADR (LKFT) had Cash Flow from Investing Activities of $189.42M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$2.69B |
|
$89.39M |
|
$1.21B |
|
$3.90B |
|
$81.77M |
|
$5.55M |
|
$20.04M |
|
$101.80M |
|
$3.79B |
|
$2.92B |
|
$3.79B |
|
-- |
|
| Cash Flow Statement Financials | |
$-135.85M |
|
|
Cash Flow from Investing Activities |
$189.42M |
$-5.17M |
|
$102.16M |
|
$158.07M |
|
$55.91M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|